Annual report for Kilitch Drugs(I) Ltd. for FY-2013
30-05-2013
Financial Results & Limited Review for Dec 31, 2012
Kilitch Drugs India Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2012.Demise of Director
Kilitch Drugs India Ltd has informed BSE about due to sad demise, Mr. Prataprai Mehta ceased to be the Chairman and Director of the Company w.e.f. February 01, 2013.Outcome of Board Meeting
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 15, 2013, was decided the following :- To disinvest company's entire stake held in Eye Kare Kilitch Ltd, being a non-listed Company, as the Board of Directors do not envisage any increase in growth on the said investment without any additional infusion of funds, which the Board do not find it feasible.Board Meeting on Jan 15, 2013
Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 15, 2013, inter alia, to consider sale of investments made by the Company.Financial Results & Limited Review for Sep 30, 2012
Kilitch Drugs India Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2012.Outcome of AGM
Kilitch Drugs India Ltd has informed BSE that the 20th Annual General Meeting (AGM) of the Company was held on September 29, 2012. (For more details kindly refer Corporate Announcements on www.bseindia.com).Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Kilitch Drugs India Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Mukund P Mehta has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Paresh P Mehta has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992